By Nick Johnson (Apyx) In 2025 Shareholder News, J-Plasma, RenuvionPosted August 7, 2025APYX MEDICAL CORPORATION REPORTS INDUCEMENT GRANT UNDER NASDAQ LISTING RULE 5635(C)(4) READ MORE
By Nick Johnson (Apyx) In 2025 Shareholder News, J-Plasma, RenuvionPosted August 7, 2025APYX MEDICAL EXPANDS GLOBAL SALES LEADERSHIP WITH STRATEGIC HIRES TO SUPPORT AYON LAUNCH AND ACCELERATED GROWTH READ MORE
By Nick Johnson (Apyx) In 2025 Shareholder News, J-Plasma, RenuvionPosted August 7, 2025APYX MEDICAL CORPORATION REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS READ MORE
By Nick Johnson (Apyx) In 2025 Shareholder News, J-Plasma, RenuvionPosted July 28, 2025APYX MEDICAL CORPORATION ANNOUNCES LAUNCH OF RENUVION® IN CHINA READ MORE
By Nick Johnson (Apyx) In 2025 Shareholder News, J-Plasma, RenuvionPosted July 24, 2025APYX MEDICAL CORPORATION TO RELEASE SECOND QUARTER OF FISCAL YEAR 2025 FINANCIAL RESULTS ON AUGUST 7, 2025 READ MORE
By Nick Johnson (Apyx) In 2025 Shareholder News, RenuvionPosted June 2, 2025Renuvion® Brings Real Transformations to the Runway at Miami Swim Week READ MORE
By Nick Johnson (Apyx) In 2025 Shareholder News, RenuvionPosted May 13, 2025APYX MEDICAL CORPORATION RECEIVES FDA CLEARANCE FOR THE AYON BODY CONTOURING SYSTEM™ READ MORE
By Nick Johnson (Apyx) In 2025 Shareholder News, J-Plasma, RenuvionPosted May 8, 2025APYX MEDICAL CORPORATION REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS READ MORE
